ESSA Pharma Inc (EPI) - Financial and Strategic SWOT Analysis Review

  • ID: 4282183
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen receptor, metastatic CRPC, and the androgen receptor as a therapeutic target. The company has collaboration with the Cancer Prevention and Research Institute of Texas (CPRIT). It has office in Houston, Texas, the US. Essa Pharma is headquartered in Vancouver, British Columbia, Canada.

ESSA Pharma Inc Key Recent Developments

Feb 13, 2018: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017
Jan 25, 2018: ESSA Pharma Announces Management Changes
Dec 11, 2017: ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017
Nov 22, 2017: ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX
Aug 14, 2017: ESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017

This comprehensive SWOT profile of ESSA Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ESSA Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • ESSA Pharma Inc - Key Information
  • ESSA Pharma Inc - Overview
  • ESSA Pharma Inc - Key Employees
  • ESSA Pharma Inc - Key Employee Biographies
  • ESSA Pharma Inc - Key Operational Heads
  • ESSA Pharma Inc - Major Products and Services
  • ESSA Pharma Inc - History
  • ESSA Pharma Inc - Company Statement
  • ESSA Pharma Inc - Locations And Subsidiaries
  • ESSA Pharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • ESSA Pharma Inc - Business Description
  • ESSA Pharma Inc - Corporate Strategy
  • ESSA Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • ESSA Pharma Inc - Strengths
  • ESSA Pharma Inc - Weaknesses
  • ESSA Pharma Inc - Opportunities
  • ESSA Pharma Inc - Threats
  • ESSA Pharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • ESSA Pharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • ESSA Pharma Inc, Key Information
  • ESSA Pharma Inc, Key Ratios
  • ESSA Pharma Inc, Share Data
  • ESSA Pharma Inc, Major Products and Services
  • ESSA Pharma Inc, History
  • ESSA Pharma Inc, Key Employees
  • ESSA Pharma Inc, Key Employee Biographies
  • ESSA Pharma Inc, Key Operational Heads
  • ESSA Pharma Inc, Other Locations
  • ESSA Pharma Inc, Subsidiaries
  • ESSA Pharma Inc, Key Manufacturing facilities
  • ESSA Pharma Inc, Key Competitors
  • ESSA Pharma Inc, SWOT Analysis
  • ESSA Pharma Inc, Ratios based on current share price
  • ESSA Pharma Inc, Annual Ratios
  • ESSA Pharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • ESSA Pharma Inc, Performance Chart
  • ESSA Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown